-+ 0.00%
-+ 0.00%
-+ 0.00%

ASCLETIS PHARMA - INITIATES TWO PHASE I OBESITY STUDIES IN U.S. FOR ASC36 AND ASC36_35FDC

Reuters·08/10/2026 10:50:50

Please log in to view news